TIRAY has been a traders dream lately. Looking on the daily chart, you notice at the top of the chart there was a huge Red DOJI candlestick signaling a reversal in the chart after an over extension in the stock price. We have since witnessed four consecutive red days, with the fourth day also closing into support with another doji star signaling consolidation in price and potential reversal to upside. An over extension to the downside into support on the 4 consecutive red day, is indicating a rubberband snap back. Once TIRAY breaks out of $120, it'll will become a strong buy with upside potential to $160.
Tilray will be at $350 by October 17th and $500 by January 1. You can’t Fantasy Football Tilray. The Amazon of Canada.
BBTrader30
⋅
@Supo, potential short squeeze may run this up in the short term
Supo
⋅
@BBTrader30, i think the long term is safe. Buy it now. Park it. Thise who bought at $17 were smart. So, next year at this time when it is trading at $750-1000....will you be sorry you bought at $100? $200? $300? Nope. Tilray is doing this so brilliantly. Do you pay more for a Coke, or more for that epilepsy medication? Achieving medical domination is where the $$$$$$ is. While any Tom, Dick and Harry is going to compete and start up quickly to the stoners, Tilray is creating a lifetime relationship one patient at a time, one clinical trial at a time, one country at a time, one hospital at a time. Tilray will be in every pharmacy worldwide because they have earned the reputation, earned the study results and while they earn the branding....the chaos is happening elsewhere.
Get your stock while you can because investment companies are wiping up the floor by people dumping them. There are so few out there floating, you will lose out.
dinerosrb
⋅
@Supo, at its peak it was worth than apple currently, do you really think a little company which is literally bleeding money would be worth AMZN prices? No